Tenon Medical

Tenon Medical EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Tenon Medical (TNON) as of Oct 22, 2026 is -0.43. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -0.21 — a change of 101.10% (lower).

EV/OCF

-0.43

YoY

101.10%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Tenon Medical is 2025 -0.43 . EV/OCF (Enterprise Value to Operating Cash Flow) of Tenon Medical was 2024 -0.21 . It decreases by 101.10% lower compared to the previous year.

The Tenon Medical EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2019
-38.19 USD
Jan 1, 2020
-51.00 USD
Jan 1, 2021
-3.61 USD
Jan 1, 2022
-0.05 USD
Jan 1, 2023
-0.63 USD
Jan 1, 2024
-0.21 USD
Jan 1, 2025
-0.43 USD
The Tenon Medical EV/OCF history
YEAREV/OCFYoY
-0.43+101.10%
-0.21-66.10%
-0.63+1,279.00%
-0.05-98.74%
-3.61-92.92%
-51.00+33.55%
-38.19—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tenon Medical Stock analysis

What does Tenon Medical do? Tenon Medical Inc generates revenue through the sale of its Catamaran SI Joint Fusion System, a medical device designed to treat sacroiliac joint disorders causing lower back pain. The system includes the Catamaran Fixation Device, which stabilizes the SI Joint by transfixing it along its longitudinal axis using a single titanium implant. The company targets orthopedic surgeons and hospitals specializing in spinal and joint treatments, with the Catamaran System marketed as a solution for the most common SI Joint disorders. Tenon Technology AG serves as the company's subsidiary, supporting the development and commercialization of the medical device technology. The Catamaran System is positioned as a specialized surgical solution, featuring a unique approach that avoids critical neural and vascular structures while targeting strong cortical bone. The company's focus on the sacroiliac joint market differentiates it from broader orthopedic device manufacturers, with the product designed to address specific patient needs in lower back pain management. Revenue streams are derived from direct sales of the system to healthcare providers and hospitals, leveraging the proprietary surgical technique and implant design. Tenon Medical Inc. operates within the Health Care Equipment & Supplies industry, with its primary product being the Catamaran SI Joint Fusion System. The company's business model centers on developing and selling medical devices that provide targeted treatment for SI Joint disorders, using a single titanium implant that transfixes the joint. The subsidiary Tenon Technology AG plays a role in supporting the company's technological advancements and market positioning. Tenon Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tenon Medical stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Tenon Medical is -0.43 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Tenon Medical changed from -0.21 to -0.43, representing a 101.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Tenon Medical since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Tenon Medical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Tenon Medical

All Key Metrics — Tenon Medical